Skip to content

The Best Evidence Summary and Application of Nutritional Intervention in Patients with Sarcopenia after Total Gastrectomy for Gastric Cancer

The Best Evidence Summary and Application of Nutritional Intervention in Patients with Sarcopenia after Total Gastrectomy for Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101271
Enrollment
Unknown
Registered
2025-04-23
Start date
2023-01-02
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Intervention Group:Oral nutritional supplement

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Part 1: Qualitative Research ??Inclusion Criteria for Healthcare Providers:?? 1. Practicing in gastrointestinal surgery for >=10 years; 2. Possessing strong communication skills; 3. Willingness to provide informed consent, voluntarily participate in the study, and undergo audio-recorded interviews. ??Inclusion Criteria for Patients:?? 1. Pathologically confirmed gastric cancer diagnosis with total gastrectomy performed; 2. Diagnosed with sarcopenia based on the ??Asian Working Group for Sarcopenia (AWGS) consensus criteria??: ??(1) Reduced muscle mass??: Appendicular skeletal muscle mass index (ASMI) adjusted for height (measured via dual-energy X-ray absorptiometry, DXA) <5.4 kg/m^2 for females or <7.0 kg/m^2 for males; ??(2) Slow gait speed??: 6-meter usual walking speed <0.8 m/s; ??(3) Weak grip strength??: <18 kg for females or <26 kg for males. Diagnosis requires either: (1)(2), (1)(2)(3), or (1)(3). 3. No prior treatment for gastric cancer; 4. Aged 18–80 years. ??Part 2: Intervention Study? 1. Patients who have been pathologically diagnosed with gastric cancer and have undergone total gastrectomy; 2. Patients who are screened for sarcopenia for the first time (the diagnosis of sarcopenia is confirmed according to the 2014 Asian Working Group's consensus criteria for the diagnosis of sarcopenia in Asia); 3. Patients who have not undergone any gastric cancer treatment before; 4. Patients aged 18 to 80 years old; 5. Patients who can communicate normally; 6. Patients who are willing to participate in the study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: Part 1: Qualitative Research 1. History of psychiatric disorders; 2. Severe systemic diseases (e.g., severe cardiac, pulmonary, hepatic, or renal dysfunction); 3. Diagnosis of dementia; 4. Inability to cooperate with study requirements. Part 2: Intervention Study? 1. Patients who have developed complications immediately after surgery that affect the method of intervention; 2. Patients who have not undergone the first follow-up as required; 3. Patients with a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Postoperative length of stay;Weight;Skeletal Muscle Mass Index;

Secondary

MeasureTime frame
Albumin;Prealbumin ;Hemoglobin;Grip strength;

Countries

China

Contacts

Public ContactYiqin Pan

Fudan University Shanghai Cancer Center

pyq-11@163.com+86 180 1731 2969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026